Publications by authors named "Marie Cazaubiel"
Article Synopsis
- The study investigates Charcot neuroarthropathy (CN) in patients with diabetes, focusing on whether hyperglycemia decreases when an active phase of CN begins.
- Researchers analyzed Hemoglobin A1c (HbA1c) levels in 103 diabetic patients before and during the active phase of CN, looking at changes over six months prior to diagnosis.
- Results indicated a significant decline in HbA1c levels from six months to three months before diagnosis and from six months to the onset of the active phase, suggesting a relationship between reduced blood sugar levels and the onset of CN.
Objective: It is unclear whether glycated haemoglobin (HbA1c) has utility in predicting adverse outcomes in gestational diabetes mellitus (GDM). The aims of the study were to examine the predictive value of HbA1c at GDM diagnosis with adverse pregnancy outcomes.
Research Design And Methods: This was a cohort study of 4,383 women with GDM between 2011 and 2018.
Importance: Randomized trials have not focused on neonatal complications of glyburide for women with gestational diabetes.
Objective: To compare oral glyburide vs subcutaneous insulin in prevention of perinatal complications in newborns of women with gestational diabetes.
Design, Settings, And Participants: The Insulin Daonil trial (INDAO), a multicenter noninferiority randomized trial conducted between May 2012 and November 2016 (end of participant follow-up) in 13 tertiary care university hospitals in France including 914 women with singleton pregnancies and gestational diabetes diagnosed between 24 and 34 weeks of gestation.
Objective: Little is known about the optimal duration of antibiotic therapy for diabetic foot osteomyelitis (DFO). This study sought to compare the effectiveness of 6 versus 12 weeks of antibiotic therapy in patients with DFO treated nonsurgically (i.e.
View Article and Find Full Text PDFObjective: The purpose of this article was to identify criteria predictive of remission in nonsurgical treatment of diabetic foot osteomyelitis.
Research Design And Methods: Diabetic patients who were initially treated without orthopedic surgery for osteomyelitis of the toe or metatarsal head of a nonischemic foot between June 2002 and June 2003 in nine French diabetic foot centers were identified, and their medical records were reviewed. Remission was defined as the absence of any sign of infection at the initial or contiguous site assessed at least 1 year after the end of treatment.
Background: We assessed the diagnostic value of swab cultures by comparing them with corresponding cultures of percutaneous bone biopsy specimens for patients with diabetic foot osteomyelitis.
Methods: The medical charts of patients with foot osteomyelitis who underwent a surgical percutaneous bone biopsy between January 1996 and June 2004 in a single diabetic foot clinic were reviewed. Seventy-six patients with 81 episodes of foot osteomyelitis who had positive results of culture of bone biopsy specimens and who had received no antibiotic therapy for at least 4 weeks before biopsy constituted the study population.